FLLL-32
CAS No. 1226895-15-3
FLLL-32( JAK2 Inhibitor X | FLLL32 )
Catalog No. M10870 CAS No. 1226895-15-3
FLLL-32 is a cell-permeable analog of curcumin that inhibits JAK2-mediated phosphorylation of STAT3 on Tyr705 in cancer cells (IC50=5 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 77 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 186 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 500MG | 797 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFLLL-32
-
NoteResearch use only, not for human use.
-
Brief DescriptionFLLL-32 is a cell-permeable analog of curcumin that inhibits JAK2-mediated phosphorylation of STAT3 on Tyr705 in cancer cells (IC50=5 uM).
-
DescriptionFLLL-32 is a cell-permeable analog of curcumin that inhibits JAK2-mediated phosphorylation of STAT3 on Tyr705 in cancer cells (IC50=5 uM); induces apoptosis in pancreatic and breast cancer cell lines; also inhibit colony formation in soft agar and cell invasion and exhibits synergy with Doxorubicin against breast cancer cells; decreases STAT3 DNA binding activity and expression, and induces apoptosis in several cancer cell lines.
-
In VitroFLLL32 specifically reduces STAT3 phosphorylation at Tyr705 (pSTAT3) and induces apoptosis at micromolar amounts in human melanoma cell lines and primary melanoma cultures.
-
In Vivo——
-
SynonymsJAK2 Inhibitor X | FLLL32
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorJAK2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1226895-15-3
-
Formula Weight464.6
-
Molecular FormulaC28H32O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 85 mg/mL (183 mM); Ethanol: 24 mg/mL (51.7 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(C1(C(/C=C/C2=CC=C(OC)C(OC)=C2)=O)CCCCC1)/C=C/C3=CC=C(OC)C(OC)=C3
-
Chemical Name(2E,2'E)-1,1'-cyclohexylidenebis[3-(3,4-dimethoxyphenyl)]-2-propen-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lin L, et al. Cancer Res. 2010 Mar 15;70(6):2445-54.
2. Bill MA, et al. Mol Cancer. 2010 Jun 25;9:165.
3. Fossey SL, et al. BMC Cancer. 2011 Mar 28;11:112.
molnova catalog
related products
-
ML116
A novel selective STAT3 inhibitor with IC50 of 4.2 uM.
-
MNK8?
3-methyl-6- (naphthalen-1-yl)pyrimidine-2,4(1H, 3H)-dione is a potent STAT3 inhibitor that reduces the ability of STAT3 to bind to DNA and also has a good growth inhibition effect on liver cancer cells .
-
HODHBt
HODHBt is a STAT5-SUMO protein-protein interaction inhibitor.
Cart
sales@molnova.com